Skip to main content
logo
Catalyst Pharmaceuticals, Inc. (CPRX)
NASDAQ: CPRX · Real-Time Price · USD
31.50
+0.08 (0.25%)
At close: Jun 26, 2026, 4:00 PM EDT
31.39
-0.11 (-0.35%)
After-hours: Jun 26, 2026, 7:54 PM EDT

Catalyst Pharmaceuticals Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
221.32214.33163.8971.4183.0839.48
Depreciation & Amortization
38.1937.8737.7732.881.240.19
Stock-Based Compensation
25.1924.7822.2514.257.916.07
Other Adjustments
-9.94-7.41-15.0262.3810.099.6
Change in Receivables
-59.57-61-11.96-43.08-3.82-0.63
Changes in Inventories
-15.62-18.09-3.9-4.741.07-3.22
Changes in Accounts Payable
-4.05-5.391.810.821.21-1.49
Changes in Accrued Expenses
17.5124.1653.855.816.395.52
Changes in Other Operating Activities
-5.16-0.58-8.87-6.13-1.114.84
Operating Cash Flow
208.21208.67239.81143.6116.0560.37
Operating Cash Flow Growth
-22.29%-12.98%67.00%23.74%92.22%34.06%
Capital Expenditures
-0.09-0.06-0.56-0.23-0.03-1.02
Purchases of Intangible Assets
----81.51--
Purchases of Investments
----13.47--10
Proceeds from Sale of Investments
----19.24-
Payments for Business Acquisitions
----198.29-10-
Investing Cash Flow
-0.09-0.06-0.56-293.59.21-11.02
Issuance of Common Stock
13.1814.67154.522.799.574.1
Repurchase of Common Stock
-1.43-27.07-0.67-0.98-7.14-12.24
Net Common Stock Issued (Repurchased)
11.75-12.4153.851.812.43-8.14
Other Financing Activities
-4.8-4.59-13.18-12.67-0.74-
Financing Cash Flow
-32.93-16.99140.67-10.861.69-8.14
Net Cash Flow
175.2191.62379.92-160.76126.9541.21
Free Cash Flow
208.13208.61239.25143.37116.0259.35
Free Cash Flow Growth
-0.23%-12.81%66.88%23.57%95.48%31.82%
FCF Margin
34.86%35.42%48.65%36.00%54.16%42.14%
Free Cash Flow Per Share
1.641.641.911.261.040.55
Levered Free Cash Flow
252.11252.25243.98109.81101.8444.31
Unlevered Free Cash Flow
230.6232.79227.96103.9999.5544.1
SEC Filings: 10-K · 10-Q